The metabolic decompensation may be life-threatening with encephalopathy and hyperammonemia [8], and neither clinical symptoms nor biochemical findings allow distinguishing RFVT1 deficiency from MADD deficiency (caused by biallelic ETFA, ETFB and ETFDH variants). Here, SLC52A1 is linked to Hyperammonemia.